M&A · Healthcare · Surgical & Medical Instruments & Apparatus
AbbVie Inc. to acquire Soliton, Inc.
Announced May 10, 2021 · Closed Dec 16, 2021
Deal value$550MEV $550M
Premium26.0%To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash$22.60 per share
Transaction
- Acquirer
- AbbVie Inc. (ABBV)
- Target
- Soliton, Inc.
- Buyer type
- Strategic
- Offer price per share
- $22.60
- Enterprise value
- $550M
- Status
- Closed Dec 16, 2021
Deal protections
- Break fee (target pays)
- $18.6M · 3.4%
- Reverse fee (buyer pays)
- $20.0M · 3.6%
- Go-shop
- No-shop
- Financing
- No financing condition
Advisors
- To the acquirer
- Not disclosed
- To the target
- Guggenheim
Sector context · Healthcare
- Comparable deals
- 17 in the prior 24 months
- Premium
- 26.0% vs. 45.0% sector median
- EV / Adj. EBITDA
- Sector median 19.3x
- Break fee
- 3.4% vs. 3.0% sector median
Timeline
- AnnouncedMay 10, 2021
- Proxy filedJun 4, 2021
- Definitive proxyJun 15, 2021
- Shareholder voteJul 20, 2021
- ClosedDec 16, 2021